EveryLife Foundation for Rare Diseases
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of EveryLife Foundation for Rare Diseases
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Health Issues
Most Frequently Disclosed Bills
Bill No. Title H.R.3737 ULTRA H.R.4132 FAST Act H.R.5661 To suspend temporarily the rate of duty on 1-Hydroxy cyclohexyl phenyl ketone. S.3187 Food and Drug Administration Safety and Innovation Act